About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

Not Yet RecruitingNANCT06735404

RAPIDE: The Feasibility of a Hybrid Care Model

Rationale: During cross-border health emergencies, such as seen with the COVID-19 pandemic, health and care services are rapidly being overwhelmed by high numbers of patients requiring care, leading t...

Lead sponsor: Radboud University Medical Center•4 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Sponsors

Lead Sponsor

Radboud University Medical Center

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•In order to be eligible to participate in this study, a subject must meet all of the following criteria:
•Patients with type 2 diabetes mellitus, WITH:
•At least 2 different types of chronic comorbidities (as defined in the list of chronic comorbidities); AND
•A high number of medical consultations at the GP practice and/or referrals to the hospital in the last 24 months, as identified by the clinical expertise of the treating GP.
•Patients with chronic heart failure, WITH:
•At least 2 different types of chronic comorbidities (as defined in the list of chronic comorbidities); AND
•A high number of medical consultations at the GP practice and/or referrals to the hospital in the last 24 months, as identified by the clinical expertise of the treating GP.

Exclusion Criteria

•Terminally ill patients
•Comorbidity of a severe psychiatric disorder (i.e. psychosis-related disorders, dementia, and bipolar disorder)
•Patients who are cognitively impaired

Related studies

RECRUITINGPhase 2

A Study of 68Ga-Fibroblast Activation Protein Inhibitor (FAPI) Positron Emission Tomography in Heart Failure

NCT07083011 · Heart Failure With Preserved Ejection Fraction

RECRUITINGPhase 3

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

NCT07037459 · Heart Failure With Preserved Ejection Fraction, Heart Failure With Mildly Reduced Ejection Fraction, and more

Contrast-Induced Acute Kidney Injury Prevention in Acute Heart Failure

NCT07550790 · Heart Failure Acute, Renal Dysfunction

An Observational Study to Learn More About the Use of Vericiguat in Korean People With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF) in Real-world Setting

NCT06148935 · Chronic Heart Failure With Reduced Ejection Fraction

A Study of Paramedic HF Management

NCT06874556 · Heart Failure

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: September 12, 2025Terms

Trial snapshot

StatusNOT_YET_RECRUITING

PhaseNA

Enrollment180

Start dateJan 2026

Last updatedSep 12, 2025

Condition

Diabetes Type 2 Heart Failure

Locations shown

Accademia Italiana Cure Primarie

Verona

University of Malta

Valletta

Radboud University Medical Center

Nijmegen

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 12, 2025Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions